The Clinical-Basic Interface in Defining Pathogenesis in Disorders of Neurodevelopmental Origin

Neuron

Volumn 67, Issue 5, 2010, Pages 702-712

  Thompson, Barbara L ^a   Levitt, Pat ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; EPHRIN; FRAGILE X MENTAL RETARDATION PROTEIN; NEUROLIGIN; NEUROLIGIN 3; SEROTONIN 1A RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTATION; AMYGDALOID NUCLEUS; BRAIN DISEASE; CELL MIGRATION; COGNITION; ENVIRONMENTAL EXPOSURE; ENZYME POLYMORPHISM; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HOMEOSTASIS; HUMAN; INFORMATION PROCESSING; LIFE EVENT; MEDICAL RESEARCH; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; PEER REVIEW; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOCIAL BEHAVIOR; SYNAPSE; SYNAPTOGENESIS; ANIMAL; COGNITION DISORDERS; COMPLICATION; DEVELOPMENTAL DISORDER; DISEASE MODEL; ENVIRONMENT; GENETICS; PATHOLOGY; SPECIES DIFFERENCE;

ANIMALS; BRAIN DISEASES; COGNITION DISORDERS; DEVELOPMENTAL DISABILITIES; DISEASE MODELS, ANIMAL; ENVIRONMENT; HUMANS; SPECIES SPECIFICITY;

EID: 77956335125     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2010.08.037     Document Type: Review

References (123)

1. Abrahams B.S., Geschwind D.H. Connecting genes to brain in the autism spectrum disorders. Arch. Neurol. 2010, 67:395-399.
2. Akil H., Brenner S., Kandel E., Kendler K.S., King M.C., Scolnick E., Watson J.D., Zoghbi H.Y. Medicine. The future of psychiatric research: genomes and neural circuits. Science 2010, 327:1580-1581.
3. Anney R., Klei L., Pinto D., Regan R., Conroy J., Magalhaes T.R., Correia C., Abrahams B.S., Sykes N., Pagnamenta A.T., et al. Hum. Mol. Genet. 2010, in press. Published online August 16, 2010. 10.1093/hmg/ddq307.
4. Auladell C., Pérez-Sust P., Supèr H., Soriano E. The early development of thalamocortical and corticothalamic projections in the mouse. Anat. Embryol. (Berl.) 2000, 201:169-179.
5. Axelrod F.B., Goldberg J.D., Ye X.Y., Maayan C. Survival in familial dysautonomia: Impact of early intervention. J. Pediatr. 2002, 141:518-523.
6. Bale T.L., Baram T.Z., Brown A.S., Goldstein J.M., Insel T.R., McCarthy M.M., Nemeroff C.B., Reyes T.M., Simerly R.B., Susser E.S., Nestler E.J. Early life programming and neurodevelopmental disorders. Biol. Psychiatry 2010, 68:314-319.
7. Banihashemi L., Rinaman L. Repeated brief postnatal maternal separation enhances hypothalamic gastric autonomic circuits in juvenile rats. Neuroscience 2010, 165:265-277.
8. Bill B.R., Geschwind D.H. Genetic advances in autism: heterogeneity and convergence on shared pathways. Curr. Opin. Genet. Dev. 2009, 19:271-278.
9. Bonnin A., Torii M., Wang L., Rakic P., Levitt P. Serotonin modulates the response of embryonic thalamocortical axons to netrin-1. Nat. Neurosci. 2007, 10:588-597.
10. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 1978, 15:339-343.
11. Buie T., Campbell D.B., Fuchs G.J., Furuta G.T., Levy J., Vandewater J., Whitaker A.H., Atkins D., Bauman M.L., Beaudet A.L., et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 2010, 125(Suppl 1):S1-S18.
12. Campbell D.B., Sutcliffe J.S., Ebert P.J., Militerni R., Bravaccio C., Trillo S., Elia M., Schneider C., Melmed R., Sacco R., et al. A genetic variant that disrupts MET transcription is associated with autism. Proc. Natl. Acad. Sci. USA 2006, 103:16834-16839.
13. Campbell D.B., Buie T.M., Winter H., Bauman M., Sutcliffe J.S., Perrin J.M., Levitt P. Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics 2009, 123:1018-1024.
14. Card J.P., Levitt P., Gluhovsky M., Rinaman L. Early experience modifies the postnatal assembly of autonomic emotional motor circuits in rats. J. Neurosci. 2005, 25:9102-9111.
15. Carneiro A.M., Airey D.C., Thompson B., Zhu C.B., Lu L., Chesler E.J., Erikson K.M., Blakely R.D. Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypes. Proc. Natl. Acad. Sci. USA 2009, 106:2047-2052.
16. Carvill S. Sensory impairments, intellectual disability and psychiatry. J. Intellect. Disabil. Res. 2001, 45:467-483.
17. Casanova M.F., Buxhoeveden D., Gomez J. Disruption in the inhibitory architecture of the cell minicolumn: implications for autisim. Neuroscientist 2003, 9:496-507.
18. Casanova M.F., Kreczmanski P., Trippe J., Switala A., Heinsen H., Steinbusch H.W., Schmitz C. Neuronal distribution in the neocortex of schizophrenic patients. Psychiatry Res. 2008, 158:267-277.
19. Caspi A., McClay J., Moffitt T.E., Mill J., Martin J., Craig I.W., Taylor A., Poulton R. Role of genotype in the cycle of violence in maltreated children. Science 2002, 297:851-854.
20. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
21. Castellanos F.X., Lee P.P., Sharp W., Jeffries N.O., Greenstein D.K., Clasen L.S., Blumenthal J.D., James R.S., Ebens C.L., Walter J.M., et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 2002, 288:1740-1748.
22. Chadman K.K., Gong S., Scattoni M.L., Boltuck S.E., Gandhy S.U., Heintz N., Crawley J.N. Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Res. 2008, 1:147-158.
23. Chahrour M., Zoghbi H.Y. The story of Rett syndrome: from clinic to neurobiology. Neuron 2007, 56:422-437.
24. Chen R.Z., Akbarian S., Tudor M., Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet. 2001, 27:327-331.
25. Christian S.L., Brune C.W., Sudi J., Kumar R.A., Liu S., Karamohamed S., Badner J.A., Matsui S., Conroy J., McQuaid D., et al. Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder. Biol. Psychiatry 2008, 63:1111-1117.
26. Cooper-Brown L., Copeland S., Dailey S., Downey D., Petersen M.C., Stimson C., Van Dyke D.C. Feeding and swallowing dysfunction in genetic syndromes. Dev. Disabil. Res. Rev. 2008, 14:147-157.
27. Courchesne E., Pierce K. Why the frontal cortex in autism might be talking only to itself: local over-connectivity but long-distance disconnection. Curr. Opin. Neurobiol. 2005, 15:225-230.
28. Cruikshank S.J., Urabe H., Nurmikko A.V., Connors B.W. Pathway-specific feedforward circuits between thalamus and neocortex revealed by selective optical stimulation of axons. Neuron 2010, 65:230-245.
29. Cruz-Martín A., Crespo M., Portera-Cailliau C. Delayed stabilization of dendritic spines in fragile X mice. J. Neurosci. 2010, 30:7793-7803.
30. Davis E., Saeed S.A., Antonacci D.J. Anxiety disorders in persons with developmental disabilities: empirically informed diagnosis and treatment. Reviews literature on anxiety disorders in DD population with practical take-home messages for the clinician. Psychiatr. Q. 2008, 79:249-263.
31. de Vrij F.M., Levenga J., van der Linde H.C., Koekkoek S.K., De Zeeuw C.I., Nelson D.L., Oostra B.A., Willemsen R. Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice. Neurobiol. Dis. 2008, 31:127-132.
32. Dölen G., Osterweil E., Rao B.S., Smith G.B., Auerbach B.D., Chattarji S., Bear M.F. Correction of fragile X syndrome in mice. Neuron 2007, 56:955-962.
33. Donoghue M.J., Rakic P. Molecular evidence for the early specification of presumptive functional domains in the embryonic primate cerebral cortex. J. Neurosci. 1999, 19:5967-5979.
34. Dragich J., Houwink-Manville I., Schanen C. Rett syndrome: a surprising result of mutation in MECP2. Hum. Mol. Genet. 2000, 9:2365-2375.
35. Dykens E.M. Anxiety, fears, and phobias in persons with Williams syndrome. Dev. Neuropsychol. 2003, 23:291-316.
36. Edwards V.J., Holden G.W., Felitti V.J., Anda R.F. Relationship between multiple forms of childhood maltreatment and adult mental health in community respondents: results from the adverse childhood experiences study. Am. J. Psychiatry 2003, 160:1453-1460.
37. Ehninger D., Li W., Fox K., Stryker M.P., Silva A.J. Reversing neurodevelopmental disorders in adults. Neuron 2008, 60:950-960.
38. El-Fishawy P., State M.W. The genetics of autism: key issues, recent findings, and clinical implications. Psychiatr. Clin. North Am. 2010, 33:83-105.
39. Errijgers V., Fransen E., D'Hooge R., De Deyn P.P., Kooy R.F. Effect of genetic background on acoustic startle response in fragile X knockout mice. Genet. Res. 2008, 90:341-345.
40. Felitti V.J., Anda R.F., Nordenberg D., Williamson D.F., Spitz A.M., Edwards V., Koss M.P., Marks J.S. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am. J. Prev. Med. 1998, 14:245-258.
41. Fisch G.S. Animal models and human neuropsychiatric disorders. Behav. Genet. 2007, 37:1-10.
42. Flint J., Shifman S. Animal models of psychiatric disease. Curr. Opin. Genet. Dev. 2008, 18:235-240.
43. Fox S.E., Levitt P., Nelson C.A. How the timing and quality of early experiences influence the development of brain architecture. Child Dev. 2010, 81:28-40.
44. Gaitatzis A., Trimble M.R., Sander J.W. The psychiatric comorbidity of epilepsy. Acta Neurol. Scand. 2004, 110:207-220.
45. Geschwind D.H. Advances in autism. Annu. Rev. Med. 2009, 60:367-380.
46. Glessner J.T., Wang K., Cai G., Korvatska O., Kim C.E., Wood S., Zhang H., Estes A., Brune C.W., Bradfield J.P., et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009, 459:569-573.
47. Grillon C., Ameli R., Charney D.S., Krystal J., Braff D. Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol. Psychiatry 1992, 32:939-943.
48. Gross C., Zhuang X., Stark K., Ramboz S., Oosting R., Kirby L., Santarelli L., Beck S., Hen R. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 2002, 416:396-400.
49. Gustin R.M., Bichell T.J., Bubser M., Daily J., Filonova I., Mrelashvili D., Deutch A.Y., Colbran R.J., Weeber E.J., Haas K.F. Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome. Neurobiol. Dis. 2010, 39:283-291.
50. Guy J., Hendrich B., Holmes M., Martin J.E., Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet. 2001, 27:322-326.
51. Guy J., Gan J., Selfridge J., Cobb S., Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 2007, 315:1143-1147.
52. Hammock E.A.D., Levitt P. The discipline of neurobehavioral development: The emerging interface of processes that build circuits and skills. Hum. Dev. 2006, 49:294-309.
53. Hayashi M.L., Rao B.S., Seo J.S., Choi H.S., Dolan B.M., Choi S.Y., Chattarji S., Tonegawa S. Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice. Proc. Natl. Acad. Sci. USA 2007, 104:11489-11494.
54. Hikida T., Jaaro-Peled H., Seshadri S., Oishi K., Hookway C., Kong S., Wu D., Xue R., Andradé M., Tankou S., et al. Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc. Natl. Acad. Sci. USA 2007, 104:14501-14506.
55. Holmes T.H., Rahe R.H. The social readjustment rating scale. J. Psychosom. Res. 1967, 11:213-218.
56. Hurvich L.M., Jameson D. An opponent-process theory of color vision. Psychol. Rev. 1957, 64:384-404.
57. Insel T.R. From animal models to model animals. Biol. Psychiatry 2007, 62:1337-1339.
58. Insel T.R. Disruptive insights in psychiatry: transforming a clinical discipline. J. Clin. Invest. 2009, 119:700-705.
59. Jiang Y.H., Armstrong D., Albrecht U., Atkins C.M., Noebels J.L., Eichele G., Sweatt J.D., Beaudet A.L. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 1998, 21:799-811.
60. Jones E.G. Thalamic circuitry and thalamocortical synchrony. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2002, 357:1659-1673.
61. Kellendonk C., Simpson E.H., Kandel E.R. Modeling cognitive endophenotypes of schizophrenia in mice. Trends Neurosci. 2009, 32:347-358.
62. Keller G., Zimmer G., Mall G., Ritz E., Amann K. Nephron number in patients with primary hypertension. N. Engl. J. Med. 2003, 348:101-108.
63. Knudsen E.I., Heckman J.J., Cameron J.L., Shonkoff J.P. Economic, neurobiological, and behavioral perspectives on building America's future workforce. Proc. Natl. Acad. Sci. USA 2006, 103:10155-10162.
64. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24:97-129.
65. Koshibu K., Levitt P. Gene x environment effects: stress and memory dysfunctions caused by stress and gonadal factor irregularities during puberty in control and TGF-alpha hypomorphic mice. Neuropsychopharmacology 2008, 33:557-565.
66. Levitt P., Campbell D.B. The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. J. Clin. Invest. 2009, 119:747-754.
67. Lewis D.A., Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci. 2002, 25:409-432.
68. Lieberman J.A., Perkins D., Belger A., Chakos M., Jarskog F., Boteva K., Gilmore J. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol. Psychiatry 2001, 50:884-897.
69. Loesch D.Z., Huggins R.M., Hagerman R.J. Phenotypic variation and FMRP levels in fragile X. Ment. Retard. Dev. Disabil. Res. Rev. 2004, 10:31-41.
70. Lupien S.J., McEwen B.S., Gunnar M.R., Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat. Rev. Neurosci. 2009, 10:434-445.
71. Matsuo M., Maeda T., Sasaki K., Ishii K., Hamasaki Y. Frequent association of autism spectrum disorder in patients with childhood onset epilepsy. Brain Dev. 2010, in press. Published online June 12, 2010. 10.1016/j.braindev.2010.05.005.
72. McEwen B.S. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 2000, 22:108-124.
73. McEwen B.S. From molecules to mind. Stress, individual differences, and the social environment. Ann. N. Y. Acad. Sci. 2001, 935:42-49.
74. McEwen B.S., Wingfield J.C. The concept of allostasis in biology and biomedicine. Horm. Behav. 2003, 43:2-15.
75. McGowan P.O., Sasaki A., D'Alessio A.C., Dymov S., Labonté B., Szyf M., Turecki G., Meaney M.J. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 2009, 12:342-348.
76. Mendl M., Burman O.H., Paul E.S. An integrative and functional framework for the study of animal emotion and mood. Proc. R. Soc. B. Biol Sci. 2010, in press. Published online August 4, 2010. 10.1098/rspb.2010.0303.
77. Mendoza S.P., Smotherman W.P., Miner M.T., Kaplan J., Levine S. Pituitary-adrenal response to separation in mother and infant squirrel monkeys. Dev. Psychobiol. 1978, 11:169-175.
78. Merikangas A.K., Corvin A.P., Gallagher L. Copy-number variants in neurodevelopmental disorders: promises and challenges. Trends Genet. 2009, 25:536-544.
79. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000, 28:53-67.
80. Mirnics K., Middleton F.A., Stanwood G.D., Lewis D.A., Levitt P. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol. Psychiatry 2001, 6:293-301.
81. Moriceau S., Wilson D.A., Levine S., Sullivan R.M. Dual circuitry for odor-shock conditioning during infancy: corticosterone switches between fear and attraction via amygdala. J. Neurosci. 2006, 26:6737-6748.
82. Mountcastle V.B. The columnar organization of the neocortex. Brain 1997, 120:701-722.
83. Mulherkar S.A., Jana N.R. Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome. Neurobiol Dis. 2010, in press. Published online August 6, 2010. 10.1016/j.nbd.2010.08.002.
84. Nakatani J., Tamada K., Hatanaka F., Ise S., Ohta H., Inoue K., Tomonaga S., Watanabe Y., Chung Y.J., Banerjee R., et al. Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell 2009, 137:1235-1246.
85. Niwa M., Kamiya A., Murai R., Kubo K., Gruber A.J., Tomita K., Lu L., Tomisato S., Jaaro-Peled H., Seshadri S., et al. Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits. Neuron 2010, 65:480-489.
86. Owen M.J., Craddock N., O'Donovan M.C. Suggestion of roles for both common and rare risk variants in genome-wide studies of schizophrenia. Arch. Gen. Psychiatry 2010, 67:667-673.
87. Paus T., Keshavan M., Giedd J.N. Why do many psychiatric disorders emerge during adolescence?. Nat. Rev. Neurosci. 2008, 9:947-957.
88. Perry W., Minassian A., Lopez B., Maron L., Lincoln A. Sensorimotor gating deficits in adults with autism. Biol. Psychiatry 2007, 61:482-486.
89. Plotsky P.M., Meaney M.J. Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Brain Res. Mol. Brain Res. 1993, 18:195-200.
90. Powell S.B., Zhou X., Geyer M.A. Prepulse inhibition and genetic mouse models of schizophrenia. Behav. Brain Res. 2009, 204:282-294.
91. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752. International Schizophrenia Consortium.
92. Radley J.J., Sisti H.M., Hao J., Rocher A.B., McCall T., Hof P.R., McEwen B.S., Morrison J.H. Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex. Neuroscience 2004, 125:1-6.
93. Rakic P. Evolution of the neocortex: a perspective from developmental biology. Nat. Rev. Neurosci. 2009, 10:724-735.
94. Ramsköld D., Wang E.T., Burge C.B., Sandberg R. An abundance of ubiquitously expressed genes revealed by tissue transcriptome sequence data. PLoS Comput. Biol. 2009, 5:e1000598.
95. Rinaman L., Levitt P., Card J.P. Progressive postnatal assembly of limbic-autonomic circuits revealed by central transneuronal transport of pseudorabies virus. J. Neurosci. 2000, 20:2731-2741.
96. Sapolsky R.M., Krey L.C., McEwen B.S. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J. Neurosci. 1985, 5:1222-1227.
97. Sato M., Stryker M.P. Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a. Proc. Natl. Acad. Sci. USA 2010, 107:5611-5616.
98. Sebat J., Lakshmi B., Malhotra D., Troge J., Lese-Martin C., Walsh T., Yamrom B., Yoon S., Krasnitz A., Kendall J., et al. Strong association of de novo copy number mutations with autism. Science 2007, 316:445-449.
99. Shahbazian M., Young J., Yuva-Paylor L., Spencer C., Antalffy B., Noebels J., Armstrong D., Paylor R., Zoghbi H. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 2002, 35:243-254.
100. Sharpe N.A., Tepper J.M. Postnatal development of excitatory synaptic input to the rat neostriatum: an electron microscopic study. Neuroscience 1998, 84:1163-1175.
101. Shaw P., Greenstein D., Lerch J., Clasen L., Lenroot R., Gogtay N., Evans A., Rapoport J., Giedd J. Intellectual ability and cortical development in children and adolescents. Nature 2006, 440:676-679.
102. Shionoya K., Moriceau S., Bradstock P., Sullivan R.M. Maternal attenuation of hypothalamic paraventricular nucleus norepinephrine switches avoidance learning to preference learning in preweanling rat pups. Horm. Behav. 2007, 52:391-400.
103. Solomon R.L., Corbit J.D. An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychol. Rev. 1974, 81:119-145.
104. Sowell E.R., Delis D., Stiles J., Jernigan T.L. Improved memory functioning and frontal lobe maturation between childhood and adolescence: a structural MRI study. J. Int. Neuropsychol. Soc. 2001, 7:312-322.
105. Stanwood G.D., Levitt P. The effects of cocaine on the developing nervous system. Handbook of Developmental Cognitive Neuroscience 2008, 83-94. MIT Press, Cambridge, MA. Second Edition. C.A. Nelson, M. Luciana (Eds.).
106. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D., Werge T., Pietiläinen O.P., Mors O., Mortensen P.B., et al. Common variants conferring risk of schizophrenia. Nature 2009, 460:744-747. Genetic Risk and Outcome in Psychosis (GROUP).
107. Suchecki D., Rosenfeld P., Levine S. Maternal regulation of the hypothalamic-pituitary-adrenal axis in the infant rat: the roles of feeding and stroking. Brain Res. Dev. Brain Res. 1993, 75:185-192.
108. Tabuchi K., Blundell J., Etherton M.R., Hammer R.E., Liu X., Powell C.M., Südhof T.C. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007, 318:71-76.
109. Thompson B.L., Levitt P. Now you see it, now you don't-closing in on allostasis and developmental basis of psychiatric disorders. Neuron 2010, 65:437-439.
110. Thompson B.L., Levitt P., Stanwood G.D. Prenatal exposure to drugs: effects on brain development and implications for policy and education. Nat. Rev. Neurosci. 2009, 10:303-312.
111. Tibbo P., Swainson J., Chue P., LeMelledo J.M. Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophrenia. Depress. Anxiety 2003, 17:65-72.
112. Torii M., Levitt P. Dissociation of corticothalamic and thalamocortical axon targeting by an EphA7-mediated mechanism. Neuron 2005, 48:563-575.
113. Torii M., Hashimoto-Torii K., Levitt P., Rakic P. Integration of neuronal clones in the radial cortical columns by EphA and ephrin-A signalling. Nature 2009, 461:524-528.
114. Trachtenberg J.T., Chen B.E., Knott G.W., Feng G., Sanes J.R., Welker E., Svoboda K. Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex. Nature 2002, 420:788-794.
115. Tropea D., Giacometti E., Wilson N.R., Beard C., McCurry C., Fu D.D., Flannery R., Jaenisch R., Sur M. Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proc. Natl. Acad. Sci. USA 2009, 106:2029-2034.
116. Uno H., Tarara R., Else J.G., Suleman M.A., Sapolsky R.M. Hippocampal damage associated with prolonged and fatal stress in primates. J. Neurosci. 1989, 9:1705-1711.
117. Vismara L.A., Rogers S.J. Behavioral treatments in autism spectrum disorder: what do we know?. Annu. Rev. Clin. Psychol. 2010, 6:447-468.
118. Wang K., Zhang H., Ma D., Bucan M., Glessner J.T., Abrahams B.S., Salyakina D., Imielinski M., Bradfield J.P., Sleiman P.M., et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009, 459:528-533.
119. Weaver I.C., Cervoni N., Champagne F.A., D'Alessio A.C., Sharma S., Seckl J.R., Dymov S., Szyf M., Meaney M.J. Epigenetic programming by maternal behavior. Nat. Neurosci. 2004, 7:847-854.
120. Weeber E.J., Jiang Y.H., Elgersma Y., Varga A.W., Carrasquillo Y., Brown S.E., Christian J.M., Mirnikjoo B., Silva A., Beaudet A.L., Sweatt J.D. Derangements of hippocampal calcium/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome. J. Neurosci. 2003, 23:2634-2644.
121. Wei Q., Hebda-Bauer E.K., Pletsch A., Luo J., Hoversten M.T., Osetek A.J., Evans S.J., Watson S.J., Seasholtz A.F., Akil H. Overexpressing the glucocorticoid receptor in forebrain causes an aging-like neuroendocrine phenotype and mild cognitive dysfunction. J. Neurosci. 2007, 27:8836-8844.
122. Weiss L.A., Shen Y., Korn J.M., Arking D.E., Miller D.T., Fossdal R., Saemundsen E., Stefansson H., Ferreira M.A., Green T., et al. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 2008, 358:667-675. Autism Consortium.
123. Yashiro K., Riday T.T., Condon K.H., Roberts A.C., Bernardo D.R., Prakash R., Weinberg R.J., Ehlers M.D., Philpot B.D. Ube3a is required for experience-dependent maturation of the neocortex. Nat. Neurosci. 2009, 12:777-783.